Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma
about
IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinomaSFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathwayNegative regulation of cytokine signaling and immune responses by SOCS proteinsModels and methods for in vitro testing of hepatic gap junctional communicationInvolvement of 14-3-3 Proteins in Regulating Tumor Progression of Hepatocellular CarcinomaThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateLinking metabolism and epigenetic regulation in development of hepatocellular carcinomaHepatitis B virus, HBx mutants and their role in hepatocellular carcinomaThe role of suppressors of cytokine signalling in human neoplasmsPromoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinomaMolecular classification and novel targets in hepatocellular carcinoma: recent advancementsTumor suppressor and hepatocellular carcinomaSilencing of Hint1, a novel tumor suppressor gene, by promoter hypermethylation in hepatocellular carcinomaImpact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinomaMethylation of the CpG sites only on the sense strand of the APC gene is specific for hepatocellular carcinomaProteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection.Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors.Promoter methylation of E-cadherin in hepatocellular carcinomas and dysplastic nodulesDNA methylation: potential biomarker in Hepatocellular Carcinoma.Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation.Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma.DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection.Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis.Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.Depletion of DNMT3A suppressed cell proliferation and restored PTEN in hepatocellular carcinoma cell.An upward trend in DNA p16ink4a methylation pattern and high risk HPV infection according to the severity of the cervical lesionEpigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targets.Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis.Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistenceInhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines.Methylation of multiple genes in hepatitis C virus associated hepatocellular carcinomaPredictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.Viral hepatocarcinogenesis: from infection to cancer.Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis.Expression of p15INK⁴b and p57KIP² and relationship with clinicopathological features and prognosis in patients with vulvar squamous cell carcinoma.Identification of direction in gene networks from expression and methylation.DNA methylation and regulation of the CD8A after duck hepatitis virus type 1 infection.
P2860
Q21261901-D59F3320-C3DC-4419-8B50-183CD351597EQ24303537-74D6A7ED-9230-445B-8A8E-FA53FF09C0EFQ24816896-0E2EFA82-785A-40E9-AD0B-A42AD4986285Q26784350-923769C1-E6B4-45C0-A3BA-0BE439FE928CQ27001182-09C5B25D-480E-4D8B-A5CD-D62721D8F6DFQ27003050-81892C99-9D8A-43DF-AEDC-E0FF6F29ED92Q27023744-B2D2769B-1794-4FE0-966C-1EF6240CF790Q27024874-6C484E39-8EEC-49F5-9049-9C1FF88C7D12Q27026783-9150E5C4-B091-428A-A30D-EF78EB724EE3Q28265788-465252D4-523A-4CAA-9093-465F71193A3DQ28383646-FA816BDF-E828-4CBE-ABC3-C91459223C58Q28389231-FCD584A9-7222-41A0-806A-FAEBFB4D6BCDQ28392002-E6315E9A-FFE0-4DBC-9182-E66178BC76D0Q28730441-7335321B-6F75-4174-B442-E24C74BD04ECQ28743228-00B7DF18-9458-4081-87A5-4C6BC35179D5Q33302217-6AFC7E01-160F-4843-8140-AB771142B5B9Q33543795-2EC1E9FC-69BD-4C65-9E51-80932947EBB5Q33599535-E5585712-F298-4A25-BCEE-D8C04DC4D35BQ33617129-F606D7C6-4069-49AA-981B-3EACAA33989CQ33647365-331EAC03-52EF-4F43-8B20-F11ECC813886Q33714992-2B30AC13-0150-4C94-897A-DA8EAF39076CQ33766987-E5501F14-F8C9-489F-A78A-F0DA189B6946Q33785451-4EFECD6A-C811-4990-9627-469DEB241C71Q33831996-D1A367AD-0472-4A9A-A482-7F5C31C8E1F9Q33847115-5CC0A5A1-FF59-4528-9A3D-8BD0162B0C04Q33926462-82C0F072-7726-4B2E-A936-8E5FC720C5D8Q33998774-EDD8E433-7677-4D9D-9EDD-FCA08887FF8CQ34004837-C4254F7A-3AE5-4343-9E1A-878C972F2787Q34157250-B9BA2B4D-2B6E-43B9-8EB7-8361A79CEFAFQ34205905-560E76AE-6BFD-4ABE-9F92-3A3E7CC83319Q34401887-D3556232-CA9D-4ECB-A6E6-66326D06F270Q34462989-76966158-1E9A-453C-8B2D-96474889F6CBQ34582041-6E219BFF-D38B-430F-9D37-DD5288827EBAQ34587991-A7DE8D7A-0C98-486B-9AAD-A4156BC402FBQ34598189-BF3187A1-636D-49A7-9B61-9173ED6279CDQ34618508-FF9F5E3D-FDEB-4BD2-86CB-AB288615DBE8Q34619389-96A1E018-884C-4ED4-A0E1-8FDBFE957563Q34666213-EA10A5ED-E1A2-4940-AA3F-E8710F1F6DE9Q35030583-F2F3C066-17C6-4178-93B8-293B6C7968B7Q35088405-405EE18B-8866-4E38-A902-3E33A7253E5D
P2860
Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Aberrant Promoter Methylation ...... es in Hepatocellular Carcinoma
@ast
Aberrant Promoter Methylation ...... es in Hepatocellular Carcinoma
@en
Aberrant Promoter Methylation ...... es in Hepatocellular Carcinoma
@nl
type
label
Aberrant Promoter Methylation ...... es in Hepatocellular Carcinoma
@ast
Aberrant Promoter Methylation ...... es in Hepatocellular Carcinoma
@en
Aberrant Promoter Methylation ...... es in Hepatocellular Carcinoma
@nl
prefLabel
Aberrant Promoter Methylation ...... es in Hepatocellular Carcinoma
@ast
Aberrant Promoter Methylation ...... es in Hepatocellular Carcinoma
@en
Aberrant Promoter Methylation ...... es in Hepatocellular Carcinoma
@nl
P2093
P2860
P3181
P1476
Aberrant Promoter Methylation ...... es in Hepatocellular Carcinoma
@en
P2093
Douglas P Clark
James G Herman
Mingzhou Guo
P2860
P304
P3181
P356
10.1016/S0002-9440(10)63469-4
P407
P577
2003-09-01T00:00:00Z